The CDC and SART released their newest fertility data from 2021. The results for Progyny -- as they have been for the last 6 years -- were encouraging:

Progyny now boasts a:

1) 17% better pregnancy rate vs. the national average (was +16% in 2020)

2) 27% better live birth rate vs. the national average (was +25% in 2020)

3) 91% single embryo transfer rate (was 90.1% in 2020)

4) 2.5% multiple birth rate (was 2.8% in 2020 and lower is generally preferred)

Not only does this make for happier, healthier mothers and children... but it is a massive cost saver for Progyny's enterprise clients purchasing these benefits and for patients. The average course of a round of treatment is $60,000 with twins and triplets costing exponentially more on average.

More frequent single births are good for every stakeholder! Employers win via savings, patients win via greater success, network doctors win via better reputations/track records and Progyny wins via brisk compounding.

Nobody can match what it provides due to competition lacking proper carrier integrations & via the restrictive lifetime dollar maximums they apply to parents (which is capped at 25% of a typical course of treatment). That's why Progyny's leads continue to grow and why Amazon, Microsoft and other behemoths use this service.